Target type: molecularfunction
Combining with basic secretagogues to initiate pseudo-allergic reactions in mast cells. [GOC:sp, PMID:25517090]
Mast cell secretagogue receptor activity is a molecular function that describes the ability of a receptor protein to bind to and be activated by mast cell secretagogues. Mast cell secretagogues are a class of molecules that trigger the release of various inflammatory mediators from mast cells, which are immune cells found in connective tissues.
The activation of mast cell secretagogue receptors leads to a cascade of signaling events within the mast cell. This cascade ultimately results in the exocytosis of granules containing various pre-formed mediators, such as histamine, proteases, and cytokines. These mediators play a critical role in allergic and inflammatory responses.
Examples of mast cell secretagogues include:
- **IgE-antigen complexes:** These complexes are formed when IgE antibodies bind to antigens, such as allergens.
- **Complement fragments:** These are small proteins that are released during the complement activation pathway, an important part of the innate immune system.
- **Neuropeptides:** These are signaling molecules produced by neurons.
- **Certain drugs and toxins:** Some drugs, such as morphine, and toxins, such as bee venom, can also act as mast cell secretagogues.
The binding of a mast cell secretagogue to its receptor can lead to different downstream effects depending on the specific receptor and the nature of the secretagogue. However, the overall outcome is often the release of inflammatory mediators that contribute to allergic reactions, inflammatory diseases, and other pathological conditions.
Therefore, mast cell secretagogue receptor activity is a crucial aspect of immune system function, particularly in the context of allergic and inflammatory responses.'
"
Protein | Definition | Taxonomy |
---|---|---|
Mas-related G-protein coupled receptor member X2 | A Mas-related G-protein coupled receptor X2 that is encoded in the genome of human. [PRO:WCB, UniProtKB:Q96LB1] | Homo sapiens (human) |
Compound | Definition | Classes | Roles |
---|---|---|---|
methadone | 6-(dimethylamino)-4,4-diphenylheptan-3-one : A ketone that is heptan-3-one substituted by a dimethylamino group at position 6 and two phenyl groups at position 4. methadone : A racemate comprising equimolar amounts of dextromethadone and levomethadone. It is a opioid analgesic which is used as a painkiller and as a substitute for heroin in the treatment of heroin addiction. Methadone: A synthetic opioid that is used as the hydrochloride. It is an opioid analgesic that is primarily a mu-opioid agonist. It has actions and uses similar to those of MORPHINE. (From Martindale, The Extra Pharmacopoeia, 30th ed, p1082-3) | benzenes; diarylmethane; ketone; tertiary amino compound | |
dextropropoxyphene | dextropropoxyphene : The (1S,2R)-(+)-diastereoisomer of propoxyphene. Dextropropoxyphene: A narcotic analgesic structurally related to METHADONE. Only the dextro-isomer has an analgesic effect; the levo-isomer appears to exert an antitussive effect. propoxyphene : A racemate of the (1R,2R)- and (1S,2R)- diastereoisomers. | 1-benzyl-3-(dimethylamino)-2-methyl-1-phenylpropyl propanoate | mu-opioid receptor agonist; opioid analgesic |
substance p | peptide | neurokinin-1 receptor agonist; neurotransmitter; vasodilator agent | |
metazocine | metazocine: more than 13 isomers available; structure given in first source | benzazocine | |
codeine | morphinane alkaloid; organic heteropentacyclic compound | antitussive; drug allergen; environmental contaminant; opioid analgesic; opioid receptor agonist; prodrug; xenobiotic | |
hydrocodone | hydrocodone : A morphinane-like compound that is a semi-synthetic opioid synthesized from codeine. Hydrocodone: Narcotic analgesic related to CODEINE, but more potent and more addicting by weight. It is used also as cough suppressant. | morphinane-like compound; organic heteropentacyclic compound | antitussive; mu-opioid receptor agonist; opioid analgesic |
morphine | Meconium: The thick green-to-black mucilaginous material found in the intestines of a full-term fetus. It consists of secretions of the INTESTINAL GLANDS; BILE PIGMENTS; FATTY ACIDS; AMNIOTIC FLUID; and intrauterine debris. It constitutes the first stools passed by a newborn. | morphinane alkaloid; organic heteropentacyclic compound; tertiary amino compound | anaesthetic; drug allergen; environmental contaminant; geroprotector; mu-opioid receptor agonist; opioid analgesic; plant metabolite; vasodilator agent; xenobiotic |
alpha-neoendorphin | alpha-neoendorphin: precursor or leucine enkephalin family | ||
thebaine | Thebaine: A drug that is derived from opium, which contains from 0.3-1.5% thebaine depending on its origin. It produces strychnine-like convulsions rather than narcosis. It may be habit-forming and is a controlled substance (opiate) listed in the U.S. Code of Federal Regulations, Title 21 Part 1308.12 (1985). (From Merck Index, 11th ed) | morphinane alkaloid; organic heteropentacyclic compound | |
levorphanol | Levorphanol: A narcotic analgesic that may be habit-forming. It is nearly as effective orally as by injection. | morphinane alkaloid | |
morphine-6-glucuronide | morphine-6-glucuronide: RN given refers to (5alpha,6alpha)-isomer | morphinane alkaloid | |
sinomenine | sinomenine: isolated from root of Sinomenium acutum; antirheumatic, antineuralgic | morphinane alkaloid | |
6-o-monoacetylmorphine | 6-O-monoacetylmorphine: RN given refers to parent cpd(5alpha,6alpha)-isomer | morphinane alkaloid | |
morphine-3-glucuronide | morphine-3-glucuronide: RN given refers to (5alpha,6alpha)-isomer | morphinane alkaloid | |
acetylcodeine | |||
codeine-6-glucuronide | codeine-6-glucuronide: structure given in first source | morphinane alkaloid | |
norcodeine | norcodeine : A morphinane-like compound that is the N-demethylated derivative of codeine. norcodeine: RN given refers to (5 alpha,6 alpha)-isomer | morphinane alkaloid | |
tan 67 | quinolines | ||
adl 5859 | |||
dynorphins | Dynorphins: A class of opioid peptides including dynorphin A, dynorphin B, and smaller fragments of these peptides. Dynorphins prefer kappa-opioid receptors (RECEPTORS, OPIOID, KAPPA) and have been shown to play a role as central nervous system transmitters. | ||
cortistatin 14 | cortistatin: a cortical neuropeptide; shows strong structural similarity to somatostatin; a neuronal depressant; has sleep-modulating activity; amino acid sequence given in first source | ||
bam 22p | |||
dynorphins | dynorphin (1-13): potent opioid peptide; see also record for dynorphin & D-Ala(2)-dynorphin (1-11) |